Guerbet

from Wikipedia, the free encyclopedia
Guerbet SA

logo
legal form Corporation
ISIN FR0000032526
founding 1926
Seat Villepinte , FranceFranceFrance 
management Jean-Jacques Bertrand
Number of employees 2,850
sales 790 million euros (2018)
Branch Pharmaceutical industry
Website www.guerbet.com
As of January 16, 2020

Guerbet is a pharmaceutical company specializing in contrast media , based in Villepinte , northeast of Paris . According to its own information, the company employs around 2,700 people worldwide and is listed in the CAC Small .

Company history

In 1901 the chemist Marcel Guerbet synthesized the iodine-containing compound lipiodol . Its potential suitability as an X-ray contrast medium was not recognized until 1918. In 1926, André Guerbet, Marcel Guerbet's son, brought it to the market as the first iodine-containing X-ray contrast medium. The diagnostic is still on the market. In 1927 the company moved to Saint-Ouen . Michel Guerbet, the son of André Guerbet, took over the company from his father in 1964. In the same year the iodine-containing diagnostic agent Telebrix ( sodium dioxitalamate ) was approved. In 1968 the company headquarters was moved to Aulnay-sous-Bois (northeast of Paris ). In 1979, with Hexabrix, another x-ray contrast medium containing iodine was brought onto the market.

With the advent of magnetic resonance imaging , the company developed contrast media for this imaging process . In 1989 Dotarem, 1993 Lumirem, 1995 Endorem and 2003 Artirem were launched as contrast media for magnetic resonance imaging.

In 1992 a branch was founded in Germany. Guerbet GmbH is based in Sulzbach (Taunus) .

In addition, the company has other branches, including in Austria, Switzerland, Belgium, the USA, China and Japan.

In July 2015, Guerbet announced the takeover of the Contrast Media and Application Systems business units from Mallinckrodt . The acquisition was completed in November 2015.

Individual evidence

  1. ↑ a b c Guerbet in figures. In: guerbert.com. Retrieved January 7, 2019 .
  2. ↑ a b c Our History. In: guerbet.com. Retrieved January 7, 2019 .
  3. ^ Offsprings of Magnetic Resonance Imaging. In: magnetic-resonance.org. Retrieved January 7, 2019 .
  4. ↑ a b Guerbet Worldwide. In: guerbet.com. Retrieved January 7, 2019 .
  5. ↑ Guerbet completes acquisition of Mallinckrodt's Contrast Media and Delivery System Business (CMDS). In: guerbet.com. Retrieved January 7, 2019 .